A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )
Clinical trial NCT02964910 · COMPLETED
Trial details
- NCT number
- NCT02964910
- Sponsor
- Xiamen Innovax Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-08-01
- Enrollment
- 475
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.